Navigation Links
Lockheed Martin Completes Acquisition of QTC Holdings Inc.
Date:9/27/2011

BETHESDA, Md., Sept. 27, 2011 /PRNewswire-FirstCall/ -- Lockheed Martin Corporation (NYSE: LMT) has completed its acquisition of QTC Holdings Inc. The company, based in Diamond Bar, Calif., is the largest provider of outsourced medical evaluation services to the U.S. Department of Veterans Affairs (VA), processing more than 450,000 evaluations last year.

Founded in 1981, QTC provides IT-enabled case management services and health care expertise to the Department of Defense, the VA and other U.S. government agencies. The acquisition was originally announced on August 22, 2011. Terms of the transaction were not disclosed.

Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 126,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation reported 2010 sales from continuing operations were $45.8 billion.

For additional information, visit our website: http://www.lockheedmartin.com


'/>"/>
SOURCE Lockheed Martin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
2. KLS Martins SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation
3. Josephine Martin Joins PhRMA as Exec VP of Public Affairs
4. Menicon Appoints Manuel Martin Chief Financial Officer for Europe
5. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
6. BioMedix™ Announces John Martin, MD, FACS, as Medical Director
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):